Skip to main content
Log in

Confirmation rates of array-CGH in day-3 embryo and blastocyst biopsies for preimplantation genetic screening

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare the confirmation rate of day-3 embryo biopsy (blastomere) and trophectoderm biopsy using array-comparative genomic hybridization (array-CGH) technology.

Methods

A blinded study was conducted to re-analyse 109 embryos previously diagnosed as chromosomally abnormal by array-CGH. Preimplantation genetic screening (PGS) was performed using array-CGH on day 3 (n = 50) or day 5 (n = 59). Partial chromosome gains or losses were excluded (n=6), and only whole chromosome aneuploidies were considered. Re-analysis of whole blastocysts was carried out following the same array-CGH protocol used for PGS.

Results

The PGS result was confirmed in the whole blastocyst in (a) 49/50 (98 %) abnormal embryos after day-3 biopsy and (b) 57/59 (96.6 %) abnormal embryos after trophectoderm biopsy. One embryo (1/50; 2 %) was diagnosed as abnormal, with monosomy 18, on day 3, and software analysis of the whole blastocyst gave a euploid result; however, a mosaic pattern was observed for monosomy 18 in the whole blastocyst. Two trophectoderm biopsy cases (3.4 %) did not have the abnormalities (trisomy 7, and trisomy 1 and 4, respectively) verified in the whole embryo. Concordance rates for both biopsy strategies and for individual chromosomes were evaluated by Fisher’s exact test and showed no significant differences.

Conclusions

Both types of biopsies showed similar high concordance rates with whole blastocyst results. Therefore, regarding the confirmation rates shown in this work, day-3 embryo biopsies can be representative of the whole embryo and both types of biopsy can be used for clinical analysis in PGS following the described array-CGH protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Warren JE, Silver RM. Genetics of pregnancy loss. Clin Obstet Gynecol. 2008;51:84–95.

    Article  PubMed  Google Scholar 

  2. Campos-Galindo I, García-Herrero S, Martínez-Conejero JA, Ferro J, Simón C, Rubio C. Molecular analysis of products of conception obtained by hysteroembryoscopy from infertile couples. J Assist Reprod Genet. 2015;32(5):839–48.

    Article  PubMed  Google Scholar 

  3. Gardner DK, Meseguer M, Rubio C, Treff NR. Diagnosis of human preimplantation embryo viability. Hum Reprod Update. 2015;21(6):727–47.

    Article  PubMed  Google Scholar 

  4. Handyside A. 24-chromosome copy number analysis: a comparison of available technologies. Fertil Steril. 2013;100:595–602.

    Article  PubMed  Google Scholar 

  5. Werner MD, Leondires MP, Schoolcraft WB, Miller BT, Copperman AB, Robins ED, et al. Clinically recognizable error rate after the transfer of comprehensive chromosomal screened euploid embryos is low. Fertil Steril. 2014;102(6):1613–8.

    Article  PubMed  Google Scholar 

  6. Sermon K, Van Steirteghem A, Liebaers I. Preimplantation genetic diagnosis. Lancet. 2004;363(9421):1633–41.

    Article  PubMed  Google Scholar 

  7. Verlinsky Y, Ginsberg N, Lifchez A, Valle J, Moise J, Strom CM. Analysis of the first polar body: preconception genetic diagnosis. Hum Reprod. 1990;5(7):826–9.

    PubMed  CAS  Google Scholar 

  8. Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. Best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod. 2011;26(1):41–6.

    Article  PubMed  CAS  Google Scholar 

  9. Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D. Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod. 2008;23(11):2596–608.

    Article  PubMed  CAS  Google Scholar 

  10. Capalbo A, Wright G, Elliott T, Ubaldi FM, Rienzi L, Nagy ZP. FISH reanalysis of inner cell mass and trophectoderm samples of previously array-CGH screened blastocysts shows high accuracy of diagnosis and no major diagnostic impact of mosaicism at the blastocyst stage. Hum Reprod. 2013;28(8):2298–307.

    Article  PubMed  CAS  Google Scholar 

  11. Delhanty JD, Harper JC, Ao A, Handyside AH, Winston RM. Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet. 1997;99(6):755–60.

    Article  PubMed  CAS  Google Scholar 

  12. Rubio C, Mercader A, Alama P, et al. Prospective cohort study in high responder oocyte donors using two hormonal stimulation protocols: impact on embryo aneuploidy and development. Hum Reprod. 2010;25(9):2290–7.

    Article  PubMed  CAS  Google Scholar 

  13. Mercader A, Valbuena D, Simón C. Human embryo culture. Methods Enzymol. 2006;420:3–18.

    Article  PubMed  CAS  Google Scholar 

  14. Mir P, Rodrigo L, Mercader A, Buendía P, Mateu E, Milán-Sánchez M, et al. False positive rate of an arrayCGH platform for single-cell preimplantation genetic screening and subsequent clinical application on day-3. J Assist Reprod Genet. 2013;30(1):143–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mamas T, Gordon A, Brown A, Harper J, SenGupta S. Detection of aneuploidy by array comparative genomic hybridization using cell lines to mimic a mosaic trophectoderm biopsy. Fertil Steril. 2012;97(4):943–7.

    Article  PubMed  CAS  Google Scholar 

  16. Mir P, Rodrigo L, Mateu E, Peinado V, Milán M, Mercader A, et al. Improving FISH diagnosis for preimplantation genetic aneuploidy screening. Hum Reprod. 2010;25(7):1812–7.

    Article  PubMed  CAS  Google Scholar 

  17. Gutiérrez-Mateo C, Colls P, Sánchez-García J, Escudero T, Prates R, Ketterson K, et al. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril. 2011;95(3):953–8.

    Article  PubMed  Google Scholar 

  18. Cobo A, Bellver J, Domingo J, et al. New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. Reprod BioMed Online. 2008;17(1):68–72.

    Article  PubMed  Google Scholar 

  19. Rubio C, Castillón G, Rodrigo L, Bellver J, Guillem A, Remohí J, et al. Improvement of clinical outcome in severe male factor infertility with embryo selection based on array-CGH: a randomized controlled trial. Fertil Steril. 2014;102 Suppl 3:e24–5.

    Article  Google Scholar 

  20. Yang Z, Liu J, Collins GS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012;5(1):24–9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod. 2010;16(8):583–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Northrop LE, Treff NR, Levy B, Scott Jr RT. SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod. 2010;16(8):590–600.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Novik V, Moulton EB, Sisson ME, Shrestha SL, Tran KD, Stern HJ, et al. The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts. Mol Cytogenet. 2014;7(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rubio C, Rodrigo L, Mir P, Mateu E, Peinado V, Milán M, et al. Use of array comparative genomic hybridization (array-CGH) for embryo assessment: clinical results. Fertil Steril. 2013;99(4):1044–8.

    Article  PubMed  CAS  Google Scholar 

  25. Rodrigo L, Mateu E, Mercader A, Cobo AC, Peinado V, Milán M, et al. New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization. Biomed Res Int. 2014;2014:517125. doi:10.1155/2014/517125.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Mir.

Ethics declarations

The present study has been approved by the CEIC (Spanish ethical committee of clinical investigation). It is a biomedical study not implying any contact with human beings (only embryo biopsies); moreover, in this blinded study, all the samples were anonymized before re-analysis.

Additional information

Capsule Similar false positive rate of array-CGH technique applied to preimplantation genetic screening on day-3 and trophectoderm embryo biopsies.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mir, P., Mateu, E., Mercader, A. et al. Confirmation rates of array-CGH in day-3 embryo and blastocyst biopsies for preimplantation genetic screening. J Assist Reprod Genet 33, 59–66 (2016). https://doi.org/10.1007/s10815-015-0605-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-015-0605-0

Keywords

Navigation